Jay M. Moyes - Jun 16, 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role
Director
Signature
/s/ Jay M. Moyes
Stock symbol
PBYI
Transactions as of
Jun 16, 2022
Transactions value $
-$60,370
Form type
4
Date filed
6/21/2022, 07:05 PM
Previous filing
Jun 17, 2022
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBYI Common Stock Sale -$60.4K -22.9K -37.36% $2.64 38.3K Jun 16, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.554 to $2.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price.